Lion Point Capital, LP Milestone Pharmaceuticals Inc. Call Options Transaction History
Lion Point Capital, LP
- $157 Million
- Q1 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding MIST
# of Institutions
47Shares Held
31.3MCall Options Held
3.3KPut Options Held
3.5K-
Black Rock Inc. New York, NY4.97MShares$6.56 Million0.0% of portfolio
-
Rtw Investments, LP New York, NY3.26MShares$4.3 Million0.09% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny2.86MShares$3.77 Million0.0% of portfolio
-
Alta Fundamental Advisers LLC New York, NY2.37MShares$3.13 Million2.21% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il2.27MShares$3 Million0.0% of portfolio
About Milestone Pharmaceuticals Inc.
- Ticker MIST
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 30,010,900
- Market Cap $39.6M
- Description
- Milestone Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of cardiovascular medicines. The company is developing etripamil, a novel channel blocker, which is in Phase III clinical trial for the treatment of paroxysmal supraventricular tachycardia in the United States and Canada; and Phase II cl...